A Justice Department probe of possible price collusion by generic drug companies could lead to criminal charges by the end of the year, Bloomberg News reported Thursday.

The investigation spans more than a dozen companies, Bloomberg reported, citing people familiar with the matter.

Shares of several generic drug makers declined following the report. Among them were Lannett Co. (LCI), which fell 26% to $17.30, Endo International PLC (ENDP), which was down 18% to $14.85 and Teva Pharmaceutical Industries Ltd. (TEVA), down 12% to $38.02.

Full story at http://www.bloomberg.com/news/articles/2016-11-03/u-s-charges-in-generic-drug-probe-said-to-be-filed-by-year-end

Write to nymonitoring@dowjones.com

(END) Dow Jones Newswires

November 03, 2016 15:53 ET (19:53 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Impax labs (NASDAQ:IPXLE)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Impax labs.
Impax labs (NASDAQ:IPXLE)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Impax labs.